217 related articles for article (PubMed ID: 12226093)
1. Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau.
Hashiguchi M; Saito T; Hisanaga S; Hashiguchi T
J Biol Chem; 2002 Nov; 277(46):44525-30. PubMed ID: 12226093
[TBL] [Abstract][Full Text] [Related]
2. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
[TBL] [Abstract][Full Text] [Related]
4. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells.
Nath R; Davis M; Probert AW; Kupina NC; Ren X; Schielke GP; Wang KK
Biochem Biophys Res Commun; 2000 Jul; 274(1):16-21. PubMed ID: 10903889
[TBL] [Abstract][Full Text] [Related]
5. A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.
Zheng YL; Amin ND; Hu YF; Rudrabhatla P; Shukla V; Kanungo J; Kesavapany S; Grant P; Albers W; Pant HC
J Biol Chem; 2010 Oct; 285(44):34202-12. PubMed ID: 20720012
[TBL] [Abstract][Full Text] [Related]
6. Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation.
Kamei H; Saito T; Ozawa M; Fujita Y; Asada A; Bibb JA; Saido TC; Sorimachi H; Hisanaga S
J Biol Chem; 2007 Jan; 282(3):1687-94. PubMed ID: 17121855
[TBL] [Abstract][Full Text] [Related]
7. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
[TBL] [Abstract][Full Text] [Related]
8. Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells.
Jämsä A; Bäckström A; Gustafsson E; Dehvari N; Hiller G; Cowburn RF; Vasänge M
Biochem Biophys Res Commun; 2006 Jun; 345(1):324-31. PubMed ID: 16678793
[TBL] [Abstract][Full Text] [Related]
9. A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells.
Zheng YL; Li BS; Amin ND; Albers W; Pant HC
Eur J Biochem; 2002 Sep; 269(18):4427-34. PubMed ID: 12230554
[TBL] [Abstract][Full Text] [Related]
10. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
Maccioni RB; Otth C; Concha II; Muñoz JP
Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
[TBL] [Abstract][Full Text] [Related]
11. No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro.
Peterson DW; Ando DM; Taketa DA; Zhou H; Dahlquist FW; Lew J
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2884-9. PubMed ID: 20133653
[TBL] [Abstract][Full Text] [Related]
12. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
13. Calpain inhibitor inhibits p35-p25-Cdk5 activation, decreases tau hyperphosphorylation, and improves neurological function after spinal cord hemisection in rats.
Hung KS; Hwang SL; Liang CL; Chen YJ; Lee TH; Liu JK; Howng SL; Wang CH
J Neuropathol Exp Neurol; 2005 Jan; 64(1):15-26. PubMed ID: 15715081
[TBL] [Abstract][Full Text] [Related]
14. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.
Shelton SB; Krishnamurthy P; Johnson GV
J Neurosci Res; 2004 Apr; 76(1):110-20. PubMed ID: 15048935
[TBL] [Abstract][Full Text] [Related]
16. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
Lopes JP; Oliveira CR; Agostinho P
Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
[TBL] [Abstract][Full Text] [Related]
17. Cdk5-p25 as a key element linking amyloid and tau pathologies in Alzheimer's disease: Mechanisms and possible therapeutic interventions.
Maitra S; Vincent B
Life Sci; 2022 Nov; 308():120986. PubMed ID: 36152679
[TBL] [Abstract][Full Text] [Related]
18. Microtubule-stimulated phosphorylation of tau at Ser202 and Thr205 by cdk5 decreases its microtubule nucleation activity.
Wada Y; Ishiguro K; Itoh TJ; Uchida T; Hotani H; Saito T; Kishimoto T; Hisanaga S
J Biochem; 1998 Oct; 124(4):738-46. PubMed ID: 9756618
[TBL] [Abstract][Full Text] [Related]
19. Physiological and pathological phosphorylation of tau by Cdk5.
Kimura T; Ishiguro K; Hisanaga S
Front Mol Neurosci; 2014; 7():65. PubMed ID: 25076872
[TBL] [Abstract][Full Text] [Related]
20. Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus.
Crespo-Biel N; Canudas AM; Camins A; Pallàs M
Neurochem Int; 2007 Jan; 50(2):435-42. PubMed ID: 17116346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
